Nagasaki Prefecture To Create Drug Trial Industry
This article was originally published in PharmAsia News
Executive Summary
Aiming to establish a drug trial industry, Nagasaki Prefecture will establish a network to link pharmaceutical companies, universities and medical facilities in April. The project will utilize new drug research results and invite major pharmaceutical companies to set up R&D centers inside the prefecture. In Japan, as the associated costs of clinic trials are higher than overseas, connecting pharmaceutical companies to commercialize academic research will help lower research costs and make trials more efficient. Nagasaki Prefecture will also absorb drug trial-related research fees. (Click for more-Japanese language
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.